INBIOS is a young, aggressive biotech Company funded in 1997 with the mission to offer global services in Peptide Chemistry.

INBIOS highly qualified staff accounts experienced people from Pharmaceutical Industry and from Academia as well. INBIOS partnerships at University of Naples provide expertise and knowledge in the area of Genomic and Proteomic in general and particularly in peptide chemistry.

In the last few years, INBIOS has also invested in proprietary R&D projects based on its know-how, in many areas of peptide application, becoming a fully technology-based company.

INBIOS is now expanding its R&D activities in the area of drug development from peptide leads in cooperation with academic and industrial partners. The company's business development strategy encourages the initiation of further collaborations in this and other areas of peptide application.

INBIOS facilities are located in Naples, within the Research Area of Italian CNR.

The location in an area in which the local scientific community is extremely focused on genomic and proteomic sciences allows scientific interactions are being developed on a routine basis.